Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Adiga Life Sciences, Inc. | INDUSTRY |
| Cetero Research, San Antonio | NETWORK |
The aim of the study is to identify changes in potential biomarkers after peptide immunotherapy for that may subsequently be developed as biomarkers that correlate with clinical efficacy.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| ToleroMune Ragweed 4 | Experimental |
| |
| ToleroMune Ragweed Regimen 3 | Experimental |
| |
| ToleroMune Ragweed Regimen 2 | Experimental |
| |
| Placebo | Placebo Comparator | Placebo |
|
| ToleroMune Ragweed Regimen 1 | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ToleroMune Ragweed | Biological | Intradermal administration 1x8 administrations, 2 weeks apart |
|
| Measure | Description | Time Frame |
|---|---|---|
| Identification of potential plasma biomarkers of response to peptide immunotherapy | Blood samples derived from the study will be submitted for proteomics analyses aimed at the identification of one or more plasma proteins whose concentration over the course of the study varies in relation to the treatment administered. The outcome will be determined on the basis of measurements from samples collected over a period commencing prior to treatment and ending 6 months following treatmen | 6 months after start of dosing |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Deepen Patel, MD, CCFP | Cetero Research, San Antonio | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cetero Research | Mississauga | Ontario | L4W 1N2 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebo | Biological | Intradermal injection 1x8 administrations, 2 weeks apart |
|